Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 820 results for "merck co"

Your first trade for Monday, March 2

Apple Inc. INTERNATIONAL BUSINESS MACHINES KEURIG GREEN MOUNT MERCK & CO., Inc. Micron Technology YUM BRANDS, Inc. Stock Market XML and JSON Data API provided by FinancialContent Services, Inc. Nasdaq quotes delayed at least 15 minutes, all ... Nation's Restaurant News, 1 hour ago

36 images for merck co

North, 3 days ago
Laboratory Equipment, 3 days ago
Jutia Group, 2 days ago
AP via Yahoo!, 3 days ago, 3 days ago
The New Age Online, 3 days ago
Sky News Australia, 3 weeks ago
Jutia Group, 2 weeks ago
Topix, 2 days ago
NBC Philadelphia, 2 days ago

MERCK : & CO., INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)

 4 Traders6 hours ago Ex-Merck Analyst Zwerko Pleads Guilty to Insider-Trading  Bloomberg1 week ago Ex-Merck analyst pleads guilty to U.S. insider trading charges  Yahoo! Finance1 week ago Ex-Merck analyst cops to insider trading in Idenix, Ardea buyouts  FierceBiotech1 week ago

Merck (MRK) Trading Near $58.43 Support Level

For a hedged play on Merck & Co Inc. ("MRK) MarketIntelligenceCenter.comaEUR(TM)s patented trade-picking algorithms selected a Jun. '15 $57.50 covered call for a net debit in the $56.19 area. That is ...
 Individual.com7 hours ago Merck (MRK) Trading Near $59.55 Resistance Level  PredictWallStreet1 week ago

Global Congestive Heart Failure Drugs Market 2015-2019 with AstraZeneca, Bristol-Myers Squibb, GSK, Merck & Co., Mylan, Novartis, Pfizer, Sanofi & Valeant Pharmaceuticals Dominating

Research and Markets ( has announced the addition of the "Global Congestive Heart Failure Drugs Market 2015-2019" report to their offering. The Global Congestive Heart Failure Drugs ...
 Individual.com16 hours ago Printed, Organic & Flexible Electronics Forecasts, Players & Opportunities Report 2015-2025  Pettinga Financial Advisors9 hours ago Hodgkin Lymphoma Therapeutics Pipeline Review 2015 - Analysis of 26 Companies  Individual.com13 hours ago Research and Markets: Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Pipeline Review 2015 - 26 Companies & 40 Drug Profiles  Wall Street Business Network13 hours ago

Merck & Co. Inc. (MRK) Closes 0.71% Down on the Day for February 27

Dow Jones component Merck & Co. Inc. ($MRK) saw its stock move -0.71% to $58.54, representing a per-share move of $0.42, on volume of 12.89 million shares for Friday. Merck & Co. Inc. currently has a total float of 2.85 billion shares and moves ...
 Equities.com2 hours ago Potential Merck (MRK) Trade Targets 2.08% Return  Individual.com1 day ago Ex-Dividende MERCK CO. per 12.03.2015  SIX Swiss Exchange1 day ago Merck & Co. Short Interest Down 21.0% in January (MRK)  Ticker Report3 days ago

NGM and Merck collaborate to develop and commercialize new biologic therapies

NGM Biopharmaceuticals, Inc. and Merck have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies. This agreement will become effective upon the expiration of the waiting period under the ...
 Individual.com1 day ago Trade of the Day: MRK Stock Fires Off Triple Buy Signals  InvestorPlace.com1 day ago Merck to acquire 15% equity stake in NGM Biopharmaceuticals  Individual.com3 days ago NGM Biopharmaceuticals partners with Merck  Individual.com3 days ago
Miami Herald

Merck and non-profit group deal allows cheaper pediatric HIV drug

(16 mins ago) Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries such as India, hard hit by the AIDS virus. The deal, announced today, ...
 Hong Kong Standard3 days ago Merck grants free license for pediatric HIV drug  Miami Herald3 days ago Drugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus. The deal, announced ...EU Commission welcomes Greek list as 'valid  AP via Yahoo!3 days ago Merck gives free license allowing cheap versions of its HIV drug for children in poor nations  Yahoo! Canada3 days ago

Merck places children's HIV drug in shared non-profit patent pool

Feb 24 (Reuters) - U.S. drugmaker Merck & Co has contributed an HIV medicine for children to an international shared patent pool in a move that should speed the development of cheap paediatric formulations for use in poor countries. The ...
 Reuters3 days ago REUTERS - Merck places children's HIV drug in shared non-profit patent pool  Namibia Press Agency3 days ago

Merck (MRK) Showing Bearish Technicals With Support At $57.44

The patented option-trade picking algorithms that power's Artificial Intelligence Center are highlighting two trades on Merck & Co Inc. ("MRK) today after it closed at ...
 Individual.com4 days ago

Merck signs license agreement with MPP for treatment of HIV-1 infection

Merck & Co., Inc. has signed a license agreement with the Medicines Patent Pool, or MPP, for its pediatric formulations of raltegravir, for use in treatment of HIV-1 infection in infants and children from four weeks to under 12 years of age. This is ...
 Individual.com2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less